Roberto Calbi
Papers
2
Total Citations
5
H-Index
2
About
Roberto Calbi is a pioneering surgeon whose work spans the frontiers of hepatobiliary and urologic oncology. His research centers on refining surgical techniques for aggressive cancers, with a particular focus on intrahepatic cholangiocarcinoma (iCCA) and advanced robotic-assisted procedures. In his highly cited 2025 narrative review, Calbi systematically analyzed emerging trends in iCCA management—including margin thickness and lymphadenectomy—providing a critical roadmap for improving the only potentially curative treatment: negative-margin resection. This work, already garnering 3 citations, underscores his influence in shaping surgical strategy for this poor-prognosis liver cancer. Simultaneously, Calbi is at the vanguard of robotic surgery innovation. His 2024 study on extraperitoneal robot-assisted radical prostatectomy using the novel Hugo™ RAS system, conducted at a high-volume robotic centre, represents one of the first evaluations of this platform for urologic oncology. With 2 citations, this initial experience demonstrates his commitment to validating next-generation surgical technologies. Through these contributions, Calbi bridges the gap between emerging surgical tools and evidence-based practice, offering clinicians actionable insights for improving outcomes in both liver and prostate cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2